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1746-21 Does Magnesium Have a Place in the Therapy of
Acute Myocardial Infarction? Significance of Early vs.
Late Reperfusion
Jonathan Lear, Robert A. Kloner. The Heart Institute, The Hospital of the Good
Samaritan, Los Angeles, California,· University ofSouthern California, Los Angeles,
California
Background: Following the conflicting conclusions of recent clinical trials,
the value of magnesium (Mgl in the management of acute myocardial infarc-
tion has been questioned. Objective: To test the hypothesis that intravenous
magnesium might reduce infarct size and to examine the influence of reper-
fusion on the efficacy of magnesium therapy. Methods: We subjected rats
to 2 protocols of coronary occlusion and reperfusion: The first group was
subjected to early reperfusion (after 45 min of ischemia). and the second
group was subjected to late reperfusion (after 90 minutes of ischemia). An-
imals were randomized to intravenous Mg sulfate or saline (control). Drugs
were given 30 minutes before coronary occlusion as a bolus of 0.5 mmolfkg
followed by an infusion of 0.014 mmol/kgfminute until 45 minutes of reper-
fusion. After 4 h of reperfusion, infarct size was assessed with triphenylte-
trazolium chloride staining and was expressed as area of necrosis (AN) as %
of area at risk (AR) (±SEM). Measurements of serum Mg in a separate group
of non-infarcted animals (n = 6) indicated significant increase in serum Mg
from 2.2 ± 0.2 meqfL at baseline to 6.0 ± 0.37 meqfL after 30 min infusion
(p < 0.01). Results:
by more than 50%. Therefore, full efficacy of K+ channel blockade may re-
quire antagonism of adrenergic influences on refractoriness. HE-93, a new
K+ channel blocker with {J adrenergic blocking activity, was tested in 13 dogs
with a healed anterior myocardial infarction (MI) that developed VF during
two minutes of circumflex artery occlusion (CAO) during sub-maximal tread-
mill exercise. HE-93 lengthened oTc by 6% (P = 0.035) and reduced heart
rate at rest (-9%, P < 0.05). during exercise (-7%; P < 0.05) and at 30 sec-
onds into CAO from 235 ± 8 to 205 ± 6 bfmin, (-13%, P < 0.0005). Eleven
dogs (85%) were protected from VF. In 7 of the 11 protected dogs, VF did
not recur in consecutive tests over a month after HE-93 administration. This
is surprising considering the 91 % reproducibility previously observed in 74
dogs using this same preparation and warrants further investigation. In 6
anesthetized dogs, HE-93 prolonged left ventricular monophasic action po-
tential (MAP) duration at paced 360 msec cycle length from 179 ± 6 to 233
± 5 msec (30%, P < 0.001) and completely prevented the effects of sym-
pathetic stimulation on MAP duration. Conclusions: HE-93 exerts a powerful
antifibrillatory effect that seems to be long lasting. The combination of {J
adrenergic antagonism and K+ channel blockade overcomes the limitations
encountered with traditional IKr blockers in preventing VF due to acute my-
ocardial ischemia accompanied with reflex sympathetic activation.
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Sharon L. Hale, Robert A. Kloner. Heart Institute, Good Samaritan Hospital, Los
Angeles, CA: University ofSouthern California, Los Angeles, CA
Premenopausal women are at lower risk of coronary heart disease than their
male counterparts, and it has been shown that estrogen treatment protects
against cardiovascular disease in postmenopausal women. The acute car-
diac effects are unknown. We investigated the effect of acute pretreatment
with estradiol on myocardial infarct size in 2 protocols, studying intact anes-
thetized female and male rabbits. 17{J-estradiol (1 mg) was given 15 min be-
fore coronary artery occlusion in the treated group; control rabbits received
vehicle. All rabbits underwent 30 min of coronary artery occlusion and 4
hrs reperfusion. Risk zone (RZ) was assessed by blue dye and infarct size
(IS) by tetrazolium staining. Differences in postischemic function were as-
sessed by dPfdt at 4 hr of reperfusion. Myocardial blood flow was similar be-
tween groups 10 min after treatment and during occlusion and reperfusion,
thus estradiol did not increase blood flow. Heart rate and systemic pressure
were also similar between groups. Estradiol levels during occlusion were
1-8 picogramfml in untreated female and male rabbits and 66 ± 28 (male)
and 352 ± 273 (female) in treated rabbits. Treated rabbits of both sexes de-
veloped significantly less necrosis. Although male rabbits had larger infarcts
than female rabbits, gender was not a significant covariate for IS. Functional
recovery at 4 hr reperfusion was not improved by estradiol in either protocol.
ences in local WT were present in MI hearts: average %WT in A was lower
than in R (27.8 ± 6.14 (sem) vs 54.0 ± 10.17: p < 0.01). In rats with large MI
(MI > 20%, n = 7). cells were longer than in sham (p < 0.05: n = 175) both in
R(143.1 ± 1.76 vs 120.9 ± 2.40 jLm) and in A (150.3 ± 1.89 vs 122.6 ± 2.02
jLm) while no changes were evidenced in cell width. Cells from A were longer
than those from R(p < 0.05). A positive correlation between MI size and cell
length was found (for A: r = 0.8, slope 0.07). Electrically-stimulated cell con-
traction (see figure, %ES: cell shortening / diastolic length: values aTe mean
± sem), was impaired in A with respect to sham (**: p < 0.05) and to R (*:
p = 0.06). Thus, during post-MI remodeling, dysfunction in A non-infarcted
regions is associated with greater myocyte elongation and dysfunction than
in R. In conclusion, local myocyte dysfunction contributes to WT impairment
in adjacent regions after MI.
5'-----------
11 :15
1746-4\ Estradiol, Administered Acutely, Protects Ischemic
Myocardium in Both Female and Male Rabbits
Late reperfusion
Mg (n ~ 11) Saline (n ~ 11)
44 ± 4 52 ± 3
45±3 45±3
10(91%) 11 (100%)
8(73%) 11 (100%)
Mg (n = 13) Saline (n ~ 12)
Early reperiusion
18±4' 39±4
46±2 45±2
12 (92%) 9(75%)
7 (54%) 7(58%)
AN/AR(%)
ARILV(%}
PVCs> 30
VT orVF
, p < 0.01
Concfusions: Our data suggest that early administration of Mg can reduce
infarct size if reperfusion occurs early. This reperfusion-dependent effect of
Mg may partially explain the conflicting results of recent clinical trials.
Group RZ(%LV) IS(% RZI dPldtt
Female Control 11 29 ± 2 23 ± 5 60 ± 6
Estradiol 10 29 ± 3 10± l' 77 ± 4
Male Control 10 35 ± 2 31 ± 5 69 ± 7
Estradiol 10 34 ± 3 16 ± 4' 68±6
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Impaired Wall Thickening of Adjacent Non-Infarcted
Myocardium is Associated with Regional Myocyte
Hypertrophy and Dysfunction During Post-Infarct
Remodeling
*p < 0.03 vs respective control group, t (% baseline) p = ns between groups by ANOVA
Conclusion: Estradiol exerts a protective effect on ischemic myocardium
that is not associated with an increase in myocardial blood flow or alteration
in hemodynamics. This is the first study, of which we are aware, showing
that acute administration of estrogen reduces infarct size.
Guido Melillo, Joao A.C. Lima, Robert M. Judd, Howard S. Silverman. Johns
Hopkins Hospital, Baltimore, MD
Wall thickening (WT) is impaired in non-infarcted regions adjacent to Myocar-
dial Infarction (MI) and is thought to be caused by mechanical overload and
geometric chamber distortion. The contribution of abnormalities intrinsic to
the myocyte to impaired WT during remodeling has not been examined. To
correlate local WT in vivo with myocyte morphology and function during LV
remodeling, magnetic resonance imaging (MRI) was performed 2 weeks af-
ter MI (left coronary artery ligation) by obtaining EKG-gated spin-echo short-
axis images (1.5 Tesla, 3 inch coil). Myocytes were isolated from 14 rats with
MI and 4 shams. Local WT in regions adjacent (A) and remote (R) to the in-
farct scar visible by MRI was correlated with cell morphology and function,
studied in myocytes isolated from A and R. MI size measured by planimetry
ranged from 5% to 30% (mean 18.7%) of the outer LV area. Regional differ-
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1746-5\ Vascular Endothelial Growth Factor Promotes
Coronary Collateral Formation After Myocardial
Infarction
Mark A. Zenker, Bassam K. Kharma, Thomas Ouertermous, James B. Atkinson,
Gregory D. Chapman. Vanderbilt University. Nashville, TN
Vascular endothelial growth factor (VEGF) is an endothelial cell mitogen
and angiogenic factor. We hypothesized that intracoronary infusion of VEGF
would promote capillary formation in a myocardial infarction (MI) model. MI
was created in 10 dogs by balloon occlusion of the proximal left anterior
descending artery for 1.5 hours. At 30 minutes and again at 4 hours after oc-
clusion, a bolus of either 30 micrograms of VEGF in treated animals (n = 5) or
normal saline (NS) in controls (n = 5) was given in the left circumflex artery.
